1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,180 | 2,310 | 22:21 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.12.25 | Careium AB: Careium comments on full-year results | 130 | GlobeNewswire (Europe) | Careium's operations are developing well, however we are currently experiencing longer sales cycles than expected in UK and Germany for product sales. This impacts net sales, profitability and cashflow.... ► Artikel lesen | |
| 02.12.25 | Careium AB: Tove Christiansson appointed CEO of Careium | 172 | GlobeNewswire (Europe) | The Board of Directors of Careium has appointed Tove Christiansson as the CEO, effective Q2 2026. She succeeds interim CEO Peter Heuman, who will remain in his current role until the transition has... ► Artikel lesen | |
| 24.10.25 | Careium AB: Careium reports third quarter results 2025 | 127 | GlobeNewswire (Europe) | The third quarter in summaryNet sales increased by 6.0 percent to SEK 213.7 million (201.7)Net sales increased by 9.4 percent adjusted for currency effectsNet sales increased despite a negative impact... ► Artikel lesen | |
| CAREIUM Aktie jetzt für 0€ handeln | |||||
| 18.08.25 | Careium AB: President & CEO Christian Walén steps down from his position and Peter Heuman appointed as interim CEO | 326 | GlobeNewswire (Europe) | Careium's Board of Directors and Careium's President and CEO Christian Walén have mutually agreed that Christian Walén steps down from the role of President and CEO, effective immediately.
"The Board... ► Artikel lesen | |
| 11.07.25 | Careium AB: Careium reports second quarter results 2025 | 205 | GlobeNewswire (Europe) | The second quarter in summary
Net sales decreased 11.9 percent to SEK 202.1 million (229.4)Reported net sales was negatively impacted with SEK 15.1 million by the accounting of financial leases in Sweden... ► Artikel lesen | |
| 13.06.25 | Careium AB: Bulletin from the extraordinary general meeting on 13 June 2025 of Careium AB (publ) | 177 | GlobeNewswire (Europe) | The extraordinary general meeting ("EGM") of Careium AB (publ), 559121-5875, (the "Company") took place today, 13 June 2025.
The EGM resolved on all proposed matters in accordance with previously published... ► Artikel lesen | |
| 24.04.25 | Careium AB: Careium reports first quarter results 2025 | 148 | GlobeNewswire (Europe) | The First Quarter in Summary
Net sales decreased 1.6 percent to SEK 207.4 million (210.7)Service sales increased 3.4 percent to SEK 160.3 million (155.0)Product sales decreased 15.5 percent to SEK 47.1... ► Artikel lesen | |
| 13.02.25 | Careium AB: Careium reports fourth quarter results 2024 | 537 | GlobeNewswire (Europe) | The Fourth Quarter in SummaryNet sales increased 14.8 percent to SEK 228.9 million (199.4)Service sales was SEK 165.9 million (154.1)Product sales was SEK 63.0 million (45.3)Gross margin increased to... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,470 | +1,74 % | Fresenius: Nach 5-Jahres-Hoch - Analysten weiter optimistisch | Der Trading-Tipp des Tages ist diesmal Fresenius. In diesem Jahr läuft es für die Aktie bisher sehr gut. Gestern erreichte das Papier sogar ein 5-Jahres-Hoch. Heute findet sich Fresenius zwar am DAX-Ende... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,110 | +1,10 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers mit einem Kursziel von 61,30 Euro auf "Overweight" belassen. Der Konzernchef sowie der Finanzvorstand hätten... ► Artikel lesen | |
| THERMO FISHER | 543,50 | -0,18 % | Schlägt Thermo Fisher zu?: Qiagen: Übernahmegerüchte schicken die Aktie auf Kursachterbahn | © Foto: Rafael Henrique - picture allianceÜbernahmegerüchte um den Diagnostikspezialisten Qiagen sorgten am Dienstag für einen rekordverdächtigen Kursanstieg. Am Mittwoch kommt die Aktie wieder etwas... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 71,14 | +0,99 % | Eurofins: Weekly Report on Share Repurchases From 12th January to 16th January 2026 | Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| DAVITA | 91,18 | +0,26 % | Here's What to Expect From DaVita's Next Earnings Report | ||
| DENTSPLY SIRONA | 11,000 | +0,87 % | Dentsply Sirona Renews U.S. Dental Technology Distribution Deal With Patterson | WASHINGTON (dpa-AFX) - Dentsply Sirona Inc. (XRAY), a manufacturer of professional dental products and technologies, on Wednesday said it has renewed its U.S. dental technology distribution... ► Artikel lesen | |
| SMITH & NEPHEW | 14,320 | +1,24 % | Smith & Nephew Plc: Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair | Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has completed the acquisition of Integrity Orthopaedics, further strengthening its sports medicine shoulder... ► Artikel lesen | |
| SONIC HEALTHCARE | 13,698 | +0,51 % | Is CSL or Sonic Healthcare the smarter ASX healthcare share buy? | ||
| DIASORIN | 73,52 | -1,21 % | Milan: Strong day for DiaSorin | ||
| FULGENT GENETICS | 24,200 | +0,83 % | FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform | ||
| PERSPECTIVE THERAPEUTICS | 2,320 | +6,42 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results | Updated interim results from the Company's [212Pb]VMT-a-NET Phase 1/2a study supporting the therapy's compelling overall clinical profile at the 5 mCi dose were presented at the ESMO Congress 2025... ► Artikel lesen | |
| IMPLANTICA | 4,465 | -0,22 % | Implantica strengthens market expansion as Italy's leading Careggi University Hospital in Florence introduces RefluxStop | VADUZ, Liechtenstein, Dec. 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device... ► Artikel lesen | |
| OMNICELL | 42,000 | -2,78 % | Omnicell stock price target raised to $53 from $46 at BofA Securities | ||
| RENALYTIX | 0,067 | 0,00 % | Renalytix PLC - Three kidneyintelX.dkd Clinical Integrations |
Das Unternehmen CAREIUM AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,42 % bei einem Aktienkurs von 2,150 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREIUM AB finden Sie auf Wallstreet Online.